Literature DB >> 9483804

Disruption of the Saccharomyces cerevisiae YAP3 gene reduces the proteolytic degradation of secreted recombinant human albumin.

S M Kerry-Williams1, S C Gilbert, L R Evans, D J Ballance.   

Abstract

Expression of recombinant human albumin (rHA) in Saccharomyces cerevisiae resulted in secretion of both mature albumin and a 45 kDa degradation product, comprising an N-terminal fragment of rHA with heterogeneous C-termini between residues 403 and 409 (Geisow et al., 1991). Site-directed mutagenesis of the human albumin gene (HA) to change Arg410 to Ala (R410A) caused a significant reduction in the amount of fragment produced. Mutation of the adjacent dibasic site Lys413 Lys414 had little effect in isolation, but in combination with the R410A mutation resulted in a further reduction in the amount of rHA fragment produced. This reduction could be duplicated with nature-identical rHA by disruption of the gene for an aspartyl protease (YAP3), alone or in conjunction with disruption of the KEX2 gene. Disruption of KEX2 alone did not result in any improvement in the degree of degradation of the rHA. Reduced degradation was also observed when an rHA-human growth hormone fusion protein was secreted from a yap3 strain, suggesting that such strains may have a general utility for heterologous protein secretion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9483804     DOI: 10.1002/(SICI)1097-0061(19980130)14:2<161::AID-YEA208>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  7 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Interdomain zinc site on human albumin.

Authors:  Alan J Stewart; Claudia A Blindauer; Stephen Berezenko; Darrell Sleep; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

3.  Modulation of chaperone gene expression in mutagenized Saccharomyces cerevisiae strains developed for recombinant human albumin production results in increased production of multiple heterologous proteins.

Authors:  T Payne; C Finnis; L R Evans; D J Mead; S V Avery; D B Archer; D Sleep
Journal:  Appl Environ Microbiol       Date:  2008-10-17       Impact factor: 4.792

4.  High-level production of animal-free recombinant transferrin from Saccharomyces cerevisiae.

Authors:  Christopher J A Finnis; Tom Payne; Joanna Hay; Neil Dodsworth; Diane Wilkinson; Philip Morton; Malcolm J Saxton; David J Tooth; Robert W Evans; Hans Goldenberg; Barbara Scheiber-Mojdehkar; Nina Ternes; Darrell Sleep
Journal:  Microb Cell Fact       Date:  2010-11-17       Impact factor: 5.328

5.  A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis.

Authors:  Mehul B Ganatra; Saulius Vainauskas; Julia M Hong; Troy E Taylor; John-Paul M Denson; Dominic Esposito; Jeremiah D Read; Hana Schmeisser; Kathryn C Zoon; James L Hartley; Christopher H Taron
Journal:  FEMS Yeast Res       Date:  2010-12-17       Impact factor: 2.796

6.  Human β-defensin-2 production from S. cerevisiae using the repressible MET17 promoter.

Authors:  Thea S B Møller; Joanna Hay; Malcolm J Saxton; Karen Bunting; Evamaria I Petersen; Søren Kjærulff; Christopher J A Finnis
Journal:  Microb Cell Fact       Date:  2017-01-18       Impact factor: 5.328

7.  Disruption of YPS1 and PEP4 genes reduces proteolytic degradation of secreted HSA/PTH in Pichia pastoris GS115.

Authors:  Min Wu; Qi Shen; Yong Yang; Sheng Zhang; Wen Qu; Jing Chen; Hongying Sun; Shuqing Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2013-03-26       Impact factor: 3.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.